These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 31227821)
21. Korean biotechs seize opportunity to list on public markets. Louët S Nat Biotechnol; 2005 Oct; 23(10):1189-90. PubMed ID: 16211042 [No Abstract] [Full Text] [Related]
22. Public markets show signs of life. Mitchell P Nat Biotechnol; 2003 Aug; 21(8):833-4. PubMed ID: 12894181 [No Abstract] [Full Text] [Related]
23. Editorial: Biotech in Russia--Phoenix reborn from the ashes. Rabinovich M Biotechnol J; 2007 Jul; 2(7):771. PubMed ID: 17615595 [No Abstract] [Full Text] [Related]
24. Special: biotech in Russia. Rabinovich M; Burghardt N; Gorzka G; Kudryashev M; Leonov A; Konov A Biotechnol J; 2007 Jul; 2(7):775-89. PubMed ID: 17615597 [No Abstract] [Full Text] [Related]
25. Michigan's next wave of biopharmaceutical entrepreneurship. Kerppola R; van de Walle M; Surine S Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575 [No Abstract] [Full Text] [Related]
26. Russia through the prism of the world biopharmaceutical market. Bairamashvili DI; Rabinovich ML Biotechnol J; 2007 Jul; 2(7):801-17. PubMed ID: 17615600 [TBL] [Abstract][Full Text] [Related]
27. From the analyst's couch: The outlook for biotech exits. Grimaldi A Nat Biotechnol; 2014 Mar; 32(3):227-8. PubMed ID: 24727772 [No Abstract] [Full Text] [Related]
28. New IGF drug stirs competition in growth factor segment. Ratner M Nat Biotechnol; 2005 Oct; 23(10):1192. PubMed ID: 16211044 [No Abstract] [Full Text] [Related]
29. Biotech industry tries to recover from 2-year lull. Brower V J Natl Cancer Inst; 2003 Mar; 95(5):348-9. PubMed ID: 12618496 [No Abstract] [Full Text] [Related]
30. HHS: POUFA reauthorization good for Americans. FDA Consum; 2002; 36(5):5. PubMed ID: 12412536 [No Abstract] [Full Text] [Related]
31. Public biotech 2013--the numbers. Lawrence S; Lahteenmaki R Nat Biotechnol; 2014 Jul; 32(7):626-32. PubMed ID: 25004227 [No Abstract] [Full Text] [Related]
32. Biotech jostles with pharma for slice of HIV market. Katsnelson A Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375 [No Abstract] [Full Text] [Related]
34. The role of the private sector in biotechnology: research and development. Feisee L Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359 [No Abstract] [Full Text] [Related]
35. Barnyard biotech--lame duck or golden goose? Powell K Nat Biotechnol; 2003 Sep; 21(9):965-7. PubMed ID: 12949546 [No Abstract] [Full Text] [Related]
36. The changing norms of the life sciences. Shorett P; Rabinow P; Billings PR Nat Biotechnol; 2003 Feb; 21(2):123-5. PubMed ID: 12560827 [No Abstract] [Full Text] [Related]